Ioxilan

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ioxilan
Ioxilan structure.png
Systematic (IUPAC) name
1-N-(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-3-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
Clinical data
AHFS/Drugs.com International Drug Names
  • US: B (No risk in non-human studies)
intravenously
Pharmacokinetic data
Bioavailability N/A
Protein binding negligible
Half-life 2 hours
Excretion Mostly renal
Identifiers
107793-72-6 N
V08AB12
PubChem CID 3743
ChemSpider 3612 YesY
UNII A4YJ7J11TG YesY
KEGG D02161 YesY
ChEMBL CHEMBL1201075 N
Chemical data
Formula C18H24I3N3O8
791.112
 N (what is this?)  (verify)

Ioxilan is a diagnostic contrast agent. It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It is marketed under the trade name Oxilan by Guerbet, L.L.C.